Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate
- PMID: 9579801
- DOI: 10.1023/a:1006992911709
Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate
Abstract
Globo H (Fuc alpha1 --> 2Galbeta1 --> 3GalNAcbeta1 --> 3Gal alpha1 --> 4Galbeta1 --> 4Glc) is a carbohydrate structure that shows enhanced expression in many human carcinomas. From mice immunized with a globo H-KLH (keyhole limpet hemocyanin) synthetic conjugate an IgG3 monoclonal antibody (mAb VK-9) was derived that recognizes the globo H structure. Serological analysis showed that the minimal structure recognized by this mAb was the tetrasaccharide sequence Fuc alpha1 --> 2Galbeta1 --> 3GalNAcbeta1 --> 3Gal. An isomeric structure with an internal alphaGalNAc linkage was also recognized but less efficiently. mAb VK-9 did not react with many related structures, such as galactosylgloboside, globoside, H type 1, H type 2 blood group structures or fucosyl-gangliotetraosyl ceramide, but did react weakly with globo A ceramide. Not only did mAb VK-9 react with carbohydrate-protein conjugates but it could also recognize globo H-ceramide and human tumor cells expressing globo H. These results suggest that globo H-KLH could be explored as a vaccine in the treatment of carcinoma patients.
Similar articles
-
Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2719-24. doi: 10.1073/pnas.97.6.2719. Proc Natl Acad Sci U S A. 2000. PMID: 10716997 Free PMC article.
-
A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.Glycoconj J. 1998 Mar;15(3):217-21. doi: 10.1023/a:1006936826730. Glycoconj J. 1998. PMID: 9579798
-
Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.Int J Cancer. 2002 May 10;99(2):207-12. doi: 10.1002/ijc.10305. Int J Cancer. 2002. PMID: 11979435
-
Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.Adv Exp Med Biol. 2001;491:369-402. doi: 10.1007/978-1-4615-1267-7_24. Adv Exp Med Biol. 2001. PMID: 14533809 Review.
-
[Recent advance in carbohydrate-based cancer vaccines].Yao Xue Xue Bao. 2012 Mar;47(3):261-70. Yao Xue Xue Bao. 2012. PMID: 22645748 Review. Chinese.
Cited by
-
A novel synthetic bipartite carrier protein for developing glycotope-based vaccines.Vaccine. 2012 Dec 14;30(52):7573-81. doi: 10.1016/j.vaccine.2012.10.041. Epub 2012 Oct 22. Vaccine. 2012. PMID: 23099332 Free PMC article.
-
Glycan chip based on structure-switchable DNA linker for on-chip biosynthesis of cancer-associated complex glycans.Nat Commun. 2021 Mar 2;12(1):1395. doi: 10.1038/s41467-021-21538-0. Nat Commun. 2021. PMID: 33654088 Free PMC article.
-
Tumor-Associated Glycan Exploits Adenosine Receptor 2A Signaling to Facilitate Immune Evasion.Adv Sci (Weinh). 2025 Jul;12(27):e2416501. doi: 10.1002/advs.202416501. Epub 2025 Jun 18. Adv Sci (Weinh). 2025. PMID: 40532063 Free PMC article.
-
Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing.Cancer Immunol Immunother. 2018 Sep;67(9):1437-1447. doi: 10.1007/s00262-018-2206-0. Epub 2018 Jul 20. Cancer Immunol Immunother. 2018. PMID: 30030557 Free PMC article.
-
Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer.Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11661-6. doi: 10.1073/pnas.0804923105. Epub 2008 Aug 8. Proc Natl Acad Sci U S A. 2008. PMID: 18689688 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources